SOURCE: HealthSonix, Inc.

April 19, 2007 10:33 ET

HealthSonix Invited to Present at the Wall Street Analyst Forum's 18th Annual Analyst Conference May 23rd at the Princeton Club, NYC

IRVINE, CA -- (MARKET WIRE) -- April 19, 2007 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) announced today that its President, Michael Ivezic, will present at the 18th Annual Analyst Conference hosted by the Wall Street Analyst Forum on May 23rd, 2007 at 10:30 a.m. EDT at The Princeton Club in New York City.

The Forum is attended by institutional investors, sell-side analysts, registered representatives or other professional investors; we invite interested investors and company's shareholders to attend the presentation. Interested parties can register at:

Mr. Ivezic will present in detail results of the latest clinical trials, international distribution contracts, new product development and marketing programs planned for the new enSonix@home personal medical device, AquaSonix Therapy expansion programs and major drug company and hospital partnerships.

"This event provides HealthSonix the opportunity to present the company to potential investors, financial analysts and financial experts within the small cap market," says Dieter Doederlein, Vice President of Business Development. "As we continue to expand and show positive results, we are excited with the opportunity to present our recent achievements and company growth plans at this forum."

HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core offerings are based on proprietary, patent pending medical technologies that use sound pulses to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pulses are 80% effective in treating the pain of arthritis. All treatments and products are safe, non-invasive and have no known side effects.

More information regarding HealthSonix and its products and services can be found on the World Wide Web at: or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information